Bank Of Montreal Mirum Pharmaceuticals, Inc. Transaction History
Bank Of Montreal
- $201 Billion
- Q2 2025
A detailed history of Bank Of Montreal transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 57,043 shares of MIRM stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,043
Previous 56,340
1.25%
Holding current value
$3.69 Million
Previous $2.54 Million
14.34%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
229Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$440 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$339 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$210 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$179 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$171 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.38B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...